IL-17 Signaling in Midbrain Neurons in Parkinson's Disease

Request Access

Demographics (2)

age_donation - Biopsie donation age (phv00396737.v1.p1)
sex - Gender of participant (phv00396738.v1.p1)

Disease Events (3)

AFFECTION_STATUS - Case control status of the subject (phv00396729.v1.p1)
Group - Disease (phv00396736.v1.p1)
H&Y stage - Hoehn and Yahr stage of the disease severity (phv00396740.v1.p1)

Race and Ethnicity (1)

race - Race of participant (phv00396739.v1.p1)

Other (23)

ANALYTE_TYPE - Analyte type (phv00396744.v1.p1)
BODY_SITE - Body site where sample was collected (phv00396743.v1.p1)
CONSENT - Consent group as determined by DAC (phv00396726.v1.p1)
DISEASE - Disease type of the sample's subject (phv00396749.v1.p1)
DISEASE_STAGE - Disease stage the of sample's subject (phv00396750.v1.p1)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00396746.v1.p1)
IL-17_TREATMENT - Type of sample treatment (phv00396748.v1.p1)
IS_TUMOR - Tumor status (phv00396745.v1.p1)
LEDD - Levodopa equivalent daily dose medication (phv00396741.v1.p1)
SAMPLE_COLLECTION_CENTER - Name of the center which prepared samples (phv00396751.v1.p1)
SAMPLE_ID - De-identified sample ID (phv00396742.v1.p1)
SAMPLE_ID - Sample ID (phv00396731.v1.p1)
SAMPLE_SOURCE - Laboratory cell type used for creating sample cell type (phv00396747.v1.p1)
SAMPLE_SOURCE - Source repository where samples originate (phv00396732.v1.p1)
SAMPLE_USE - Sample Use (phv00396734.v1.p1)
SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00396752.v1.p1)
SOURCE_SAMPLE_ID - Sample ID used in the Source Repository (phv00396733.v1.p1)
SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00396728.v1.p1)
SUBJECT_ID - De-identified subject ID (phv00396735.v1.p1)
SUBJECT_ID - Subject ID (phv00396725.v1.p1)
SUBJECT_ID - Subject ID (phv00396730.v1.p1)
SUBJECT_SOURCE - Laboratory cell line used for creating samples (phv00396753.v1.p1)
SUBJECT_SOURCE - Source repository where subjects originate (phv00396727.v1.p1)